MENU

Can Rocket Lab USA (RKLB) Stock Reach $105?

A.I.Advisor
published price charts
A.I.Advisor
Nov 09, 2026

Can Rocket Lab USA (RKLB) Stock Reach $105?

Key Takeaways

  • The central target of $105 is the arithmetic mean of roughly 20 verified, current analyst price targets for Rocket Lab USA, Inc. (RKLB), a NASDAQ-listed launch and space systems company.
  • Against the latest close near $58.80, reaching $105 would require a gain of roughly 79%, a very large move from current levels.
  • Individual targets span a wide range from approximately $60 to $150, reflecting sharp disagreement over valuation and the timing of the Neutron rocket program.
  • The strongest supports are rapid revenue growth, strong Electron demand, national-security contracts, and the planned Iridium acquisition.
  • The biggest risks are the Neutron launch delay into 2027, persistent losses, a premium valuation, and acquisition-related dilution.
  • Readers can explore more about this ticker's Major News, Today's Price Move, Forecast, and Earnings on dedicated pages.
  • For AI-driven market scanning across the broader market, explore Trending AI Robots.

Analyst Price Targets and Consensus View

This is a stock with ample analyst coverage, so the central target is analyst-derived. Reviewing roughly 20 current, individually attributed price targets from firms including Morgan Stanley ($105, Nov. 6, 2026), Cantor Fitzgerald ($122), Needham ($120), Deutsche Bank ($120), KeyBanc ($135), Stifel ($132), Roth MKM ($130), Bank of America ($110), Citigroup ($105), and Goldman Sachs ($67, Hold) produces an arithmetic mean of approximately $105, rounded to a clean $105. The full range runs from about $60 (Wells Fargo) up to $150 at the high end.

The average analyst rating is a consensus "Buy," with a clear majority of Buy or Overweight ratings and only a handful of Holds. Cautious analysts, such as Goldman Sachs, point to valuation and execution risk, while bulls argue the market undervalues Rocket Lab's vertically integrated launch and space-systems platform. Notably, several firms trimmed targets after the Neutron delay was announced, including Citizens JMP (to $90 from $130) and Goldman Sachs (to $67 from $75), whereas Morgan Stanley reiterated its $105 Buy on the view that the delay was a timing setback rather than a thesis change.

Current Market Position and Path Toward the Target

At the most recent verified close near $58.80, the stock sits well below its 52-week high of roughly $151 reached in late May 2026, and above its 52-week low near $37.57. Reaching $105 implies an upside of about 79% — a very large move. The path would likely depend on demonstrating Neutron launch progress, converting the pending Iridium acquisition into accretive revenue, and moving toward positive free cash flow while sustaining the rapid top-line growth that has driven the stock's historical re-rating.

What Could Support a Move Toward the Target

Rocket Lab's revenue continues to grow quickly. In its third quarter, revenue rose about 73% year-over-year to roughly $268 million, beating expectations, and management guided fourth-quarter revenue to between $270 million and $290 million. The Electron rocket has established commercial credibility, and the company is expanding into national-security and defense work. The planned Iridium acquisition would add a satellite-communications and services layer, which several analysts view as strengthening a diversified space platform and improving long-term cash-flow visibility.

What Could Prevent the Target From Being Reached

The company is not yet profitable: third-quarter EPS (earnings per share) missed estimates, and adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) remains negative. The first Neutron launch has slipped from late 2026 into 2027 after a defect was found in a first-stage tank component, delaying a key growth catalyst. The roughly $8 billion Iridium deal raises concerns about integration cost and shareholder dilution from newly issued equity. Finally, the stock trades at a premium valuation — investors have cited figures near 39 times enterprise value to sales — leaving limited room for error if growth or execution disappoints.

Technical Levels and Market Structure

RKLB trades far below its prior peak near $151, meaning the stock has given back a large portion of its 2026 rally. The 52-week low near $37.57 marks a meaningful support zone, while the prior highs in the $150 area represent long-term resistance. Round-number levels such as $100 and the analyst-heavy zone near $120–$135 could act as psychological and technical waypoints if the stock were to recover toward the central target.

Time Horizon and What Investors Should Monitor

Analyst price targets typically reflect a research horizon of roughly 12 months, though individual firms differ. Investors should monitor Neutron launch milestones and any revised timelines, the closing and integration of the Iridium acquisition, quarterly revenue growth and progress toward profitability, guidance updates, and analyst target revisions. Given the wide target range, shifts in sentiment around valuation and execution will matter as much as headline results.

AI Daily Buy/Sell Signals

Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Traders can use these signals to discover opportunities, track positions, and spot shifting trends more efficiently than manual screening. Exploring the AI Daily Buy/Sell Signals can add an automated, data-driven layer to your market monitoring.

Final Assessment

Whether RKLB can reach $105 depends on execution as much as narrative. The target is a genuine analyst-derived average, but the $60-to-$150 range underscores how much the answer hinges on assumptions about Neutron, the Iridium integration, and the path to profitability. Rapid revenue growth and a strong competitive position in launch and space systems support the bullish case, while the launch delay, ongoing losses, a premium valuation, and dilution risk are the principal obstacles. The central target represents a very large move of about 79% from current levels and is best understood as an aggregate of widely varying analyst views rather than a guarantee. Investors should watch Neutron progress, Iridium closing details, and margin trends before drawing conclusions.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

View a ticker or compare two or three
Interact to see
Advertisement

RKLB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RKLB has been closely correlated with LUNR. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if RKLB jumps, then LUNR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RKLB
1D Price
Change %
RKLB100%
+6.54%
LUNR - RKLB
79%
Closely correlated
-1.91%
FLY - RKLB
78%
Closely correlated
-2.51%
VOYG - RKLB
72%
Closely correlated
+4.01%
PL - RKLB
68%
Closely correlated
-0.70%
SATL - RKLB
62%
Loosely correlated
-1.64%
More

Groups containing RKLB

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RKLB
1D Price
Change %
RKLB100%
+6.54%
RKLB
(6 stocks)
87%
Closely correlated
+3.99%
Can Rocket Lab USA (RKLB) Stock Reach $105?